With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
Edmund J. Pezalla, MD, MPH, Describes Aetna’s Approach to Managing Obesity
Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says that Aetna recognizes the implications of the obesity epidemic and how it contributes to a variety of other medical problems such as diabetes and hypertension.
AJMC INTERVIEWS
Christine Strahl, PharmD, MBA, BCPS, Discusses Channels and Methods for Specialty Pharmacy Distribution
Christine Strahl, PharmD, MBA, BCPS, specialty pharmacy program manager, HealthPartners, says there are several new distribution channels in specialty pharmacy.
AJMC INTERVIEWS
Amy Tenderich Explains the Value of Patient-Centered Diabetes Care
Amy Tenderich of DiabetesMine.com, a web-based news source for persons with diabetes, took part in panel discussions at “Patient-Centered Diabetes Care: Putting Theory into Practice,” sponsored by The American Journal of Managed Care.
Episdoe 9 - Benefit Design and Making Treatment Affordable
Dr Dunn introduces the discussion of benefit design, suggesting that managed care providers may be unprepared to administer specialty drugs.
March 2014
Current Issue | Archives

March 2014

Volume: 20
Number: 3
Susannah Higgins, MS; Ravi Chawla, MBA; Christine Colombo, MBA; Richard Snyder, MD; and Somesh Nigam, PhD
Christopher S. Hollenbeak, PhD; Mark G. Weiner, MD; and Barbara J. Turner, MD, MSED
Caterina F. Hill, MSc, MA (Cantab); Brian W. Powers, AB; Sachin H. Jain, MD, MBA; Jennifer Bennet, BS; Anthony Vavasis, MD; and Nancy E. Oriol, MD


March/April 2014
Current Issue | Archives

March/April 2014

Volume: 6
Number: 2
Sara C. Erickson, PharmD; Wenyi Qiu, MS; Crystal R. Maas-Patel, PharmD; Sharon M. Wang, PharmD, MS; and Bimal V. Patel, PharmD, MS
Catherine I. Starner, PharmD, BCPS; R. Scott McClelland, PharmD; Yang Qiu, MS; Richard A. Zabinski, PharmD; Nancy Cotter, PharmD; and Patrick P. Gleason, PharmD, BCPS, FCCP



Friday, April 18th, 2014
New Medicaid Generic Reimbursement Rates Receive Push Back
Katie Sullivan, MA
A US Department of Health and Human Services (HHS) analysis determined that a new payment formula, which would reduce Medicaid reimbursement rates for generic prescription drugs, could save Medicaid up to $1.2 billion per year. So why are pharmacists and drug manufacturers pushing back?

Groundbreaking hepatitis C therapies represent a new era in treatment. But their cost is unprecedented, meaning health plans and PBMs are facing difficult formulary decisions.
Previous TabNext Tab